Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Key Role Discovered for Enzyme in Preserving Essence of Stem Cells

By LabMedica International staff writers
Posted on 29 Aug 2012
A highly conserved yet unique acetyltransferase has now been shown to be essential in maintaining the self-renewal and pluripotent capacities of embryonic stem cells.

A team of scientists, primarily from the University of Michigan Medical School (Ann Arbor, MI, USA), have discovered that Mof, the only histone acetyltransferase known to be important in the functioning of non-differentiated embryonic stem cells (ESCs), is involved in regulating the core transcription mechanism in those cells by epigenetically marking chromatin to keep parts of the genome readily accessible. More...
In ESCs, many areas of DNA are kept open for access, probably because they also need to produce many proteins that prevent differentiation. Once an ESC starts to differentiate, parts of the DNA close up and are no longer as accessible. Many scientific teams have studied this “selective silencing” and the factors that cause ESCs to start specializing by reading only certain genes. But few have looked at the crucial but little understood factors that facilitate broad-range DNA transcription to preserve “stem-ness”.

“If you think about stem cell biology, the self-renewal is one aspect that makes stem cells unique and powerful, and the differentiation is another,” says lead scientist Yali Dou, PhD and associate professor of pathology and biological chemistry. “People have looked a lot at differentiation to make cells useful for therapy in the future – but the stem cell itself is actually pretty fascinating.” Prof. Dou and her team have also reported on the protein WDR5 that places chromatin tags important during transcription, but Mof appears to control the process that actually allows cells to determine which genes to transcribe. “Mof marks the areas that need to stay open and maintains the potential to become anything,” Prof. Dou explains. The findings of the current extensive study, published on August 3, 2012, in the journal Cell Stem Cell, also include that ESC Mof-deletion mutants lose characteristic morphology, alkaline phosphatase (AP) staining, and differentiation potential. Furthermore, these mutants have aberrant expression of the core transcription factors Nanog, Oct4, and Sox2.

The new findings may also have particular importance for work on induced pluripotent stem cells (IPSCs), stem cells made from “adult” tissue. IPSC research holds promise for disease treatment as it could allow patients to be treated with stem cells made from their own tissue. But the current way of making IPSCs from tissue involves a process that uses a cancer-causing gene, a step that might give doctors and patients pause. Prof. Dou says that further work on Mof might make it possible to stop using this potentially harmful approach.

Related Links:

University of Michigan Health System




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.